(Q42057831)

15 October 2017

title

Development and validation of an intact cell assay for protein tyrosine phosphatases using recombinant baculoviruses (English)

1 reference

15 October 2017

Cromlish WA

1

1 reference

15 October 2017

Payette P

series ordinal

2

1 reference

15 October 2017

Kennedy BP

series ordinal

3

1 reference

15 October 2017

language of work or name

English

0 references

publication date

1 November 1999

1 reference

15 October 2017

published in

Biochemical Pharmacology

1 reference

15 October 2017

volume

58

1 reference

15 October 2017

issue

10

1 reference

15 October 2017

page(s)

1539-1546

1 reference

1002 protein phosphatases?

15 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900242-7

Protein tyrosine phosphatases in signal transduction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900242-7

Protein-tyrosine phosphatases: biological function, structural characteristics, and mechanism of catalysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900242-7

CD45: a leukocyte-specific member of the protein tyrosine phosphatase family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900242-7

Correlation between Src family member regulation by the protein-tyrosine-phosphatase CD45 and transmembrane signaling through the T-cell receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900242-7

Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900242-7

Microinjection of a protein-tyrosine-phosphatase inhibits insulin action in Xenopus oocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900242-7

Osmotic loading of neutralizing antibodies demonstrates a role for protein-tyrosine phosphatase 1B in negative regulation of the insulin action pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900242-7

Protein tyrosine phosphatase 1B interacts with the activated insulin receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900242-7

Potent Inhibition of Insulin Receptor Dephosphorylation by a Hexamer Peptide Containing the Phosphotyrosyl Mimetic F2Pmp

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900242-7

Selective inhibition of cyclooxygenase-1 and -2 using intact insect cell assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900242-7

Mechanism of inhibition of protein-tyrosine phosphatases by vanadate and pervanadate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900242-7

CD45 modulates phosphorylation of both autophosphorylation and negative regulatory tyrosines of Lyn in B cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900242-7

The nontransmembrane tyrosine phosphatase PTP-1B localizes to the endoplasmic reticulum via its 35 amino acid C-terminal sequence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900242-7

Activation of peripheral large granular lymphocytes with the serine/threonine phosphatase inhibitor, okadaic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900242-7

Tumor necrosis factor-alpha, a new tumor promoter, engendered by biochemical studies of okadaic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900242-7

Reversible inactivation of protein-tyrosine phosphatase 1B in A431 cells stimulated with epidermal growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900242-7

Requirement for generation of H2O2 for platelet-derived growth factor signal transduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900242-7

Folding and stability of the Z and S(iiyama) genetic variants of human alpha1-antitrypsin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900242-7

Phenylarsine oxide and vanadate: apparent paradox of inhibition of protein phosphotyrosine phosphatases in rat adipocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900242-7

Inhibition of membrane phosphotyrosyl-protein phosphatase activity by vanadate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900242-7

Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900242-7

Peroxide(s) of vanadium: a novel and potent insulin-mimetic agent which activates the insulin receptor kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900242-7

Pervanadate [peroxide(s) of vanadate] mimics insulin action in rat adipocytes via activation of the insulin receptor tyrosine kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900242-7

Peroxovanadium compounds: biological actions and mechanism of insulin-mimesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900242-7

In vivo effects of peroxovanadium compounds in BB rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900242-7

10.1016/S0006-2952(99)00242-7

7 January 2021

Identifiers

DOI

1 reference

15 October 2017

1 reference